Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib vs Placebo in Progressive Carcinoid Tumors
NCT01841736Phase 2Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Sep 2013
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pazopanib in Carcinoid Tumor (CT), sponsored by National Cancer Institute. Started Sep 2013; status: active, not recruiting.
02
Drugs
pazopanib
03
Conditions
Carcinoid Tumor (CT)
Beyond the preview
Go deeper on NCT01841736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01841736.